Marvin H. Johnson's Insider Trades & SAST Disclosures
Marvin H. Johnson's most recent trade in Marinus Pharmaceuticals Inc was a trade of 1,610 Common Stock done at an average price of $0.5 . Disclosure was reported to the exchange on Jan. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Marvin H. Johnson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Marinus Pharmaceuticals Inc | Marvin H. Johnson | Director | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 21 Jan 2025 | 1,610 | 12,490 (0%) | 0% | 0.5 | 869 | Common Stock |
| Marinus Pharmaceuticals Inc | Marvin H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 10,450 | 10,450 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Marvin H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 2,300 | 14,100 (0%) | 0% | 0 | Common Stock | |
| Trevena Inc | Marvin H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 13,700 | 13,700 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Johnson Marvin H. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | H. Johnson Marvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 4,600 | 11,800 (0%) | 0% | 0 | Common Stock | |
| Trevena Inc | Marvin H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 13,700 | 13,700 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Marvin H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 32,400 | 32,400 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Marvin H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 7,200 | 7,200 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges